Skip to main content
. Author manuscript; available in PMC: 2023 Jul 15.
Published in final edited form as: Am J Cardiol. 2022 Nov 29;187:10–17. doi: 10.1016/j.amjcard.2022.10.019

Table 2.

Cardiovascular disease risk factors at baseline and at 8 weeks after intervention

Control F/V DASH F/V vs Control DASH vs control DASH vs F/V
Systolic blood pressure, mm Hg Baseline, mean (SE) 131.3 (0.95) 131.6 (0.95) 131.1 (0.95)
8-wk, mean (SE) 129.9 (0.9) 127.8 (0.9) 124.4 (0.9)
Absolute difference, mean (95% CD −1.3 (−2.5, −0.2) −3.8 (−5.0, −2.7) −6.7 (−7.8, −5.5) −2.5 (−4.2, −0.8) −5.3 (−7.0, −3.7) −2.8 (−4.5, −1.2)
Total cholesterol, mg/100 ml Baseline, mean (SE) 191.4 (2.85) 194.8 (2.84) 187.1 (2.84)
8-wk, mean (SE) 195.0 (2.9) 194.7 (2.8) 177.6 (2.8)
Absolute difference, mean (95% CD 3.6 (−0.2, 7.5) −0.2 (−4.0, 3.6) −9.5 (−13.3, −5.7) −3.8 (−9.2, 1.6) −13.1 (−18.5, −7.7) 9.3 (−14.7, 3.9)
HDL cholesterol, mg/100 ml Baseline, mean (SE) 48.2 (1.16) 47.9 (13.9) 48.5 (1.15)
8-wk, mean (SE) 48.4 (1.2) 47.9 (1.2) 45.0 (1.2)
Absolute difference, mean (95% CI) 0.3 (−0.7, 1.3) 0.0 (−1.0, 1.0) −3.5 (−4.5, −2.5) −0.2 (−1.7, 1.2) −3.8 (−5.2, −2.4) −3.5 (−5.0, −2.1)

Statistically significant differences (p <0.05) are denoted in bold. Presented as mean (SE).